MedTrace Logo

Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction

NCT01562353 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2013-09-16

No results posted yet for this study

Summary

This is a clinical study on patients who have been prescribed opioids (narcotic pain relievers) for the treatment of pain, to determine what genetic factors influence outcome of treatment. Procedures include: an initial telephone prescreening, completion of a number of questionnaires, and a blood draw to determine genetic factors. Participants will take part in a one-time clinic visit, during which all procedures will be completed.

The investigators hypothesize that several classes of genes, including genes in opioid, pain, and reward pathways, will differentiate opioid-dependent subjects from opioid-exposed nondependent subjects.

Conditions

  • Usage of Prescription Opioids

Sponsors & Collaborators

  • Analgesic Solutions

    lead INDUSTRY

Principal Investigators

  • Nathaniel P Katz, MD, MS · Analgesic Solutions

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01562353 on ClinicalTrials.gov